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INTRODUCTION
Inhibitors such as acetazolamide, amiloride, ouabain, and phlorizin are useful in identifying biochemical sites involved in the movement of various solutes across specific membrane systems. The usefulness of inhibitors, however, is limited by the extent to which we know their mechanisms. We know that arsenate inhibits phosphate transport in a number of systems including the mammalian kidney (1), Ehrlich ascites tumor cells (2) , yeast (3) , bacteria (4), Euglena (5) , and isolated membrane vesicles derived from renal brush border material (6) , but the mechanisms of inhibition are uncertain. Arsenate may interfere with phosphate transport by direct competition at some transport site (2) (3) (4) (5) (6) , or by inhibiting the activity of glycolytic enzymes such as glyceraldehyde 3-phosphate dehydrogenase (7) , or by the uncoupling of oxidative phosphorylation at the mitochondrial level (8) .
The objective of these studies is to gain frirther information on the biochemical sites where sodium transport interacts with the transport of phosphate and other solutes handled significantly by the proximal convoluted tubule. As with certain organic solutes (9) that may have metabolic as well as transport effects, the possible contributions of intraluminal phosphate to cotransport and intracellular metabolism must be separated conceptually and experimentally. In this regard, we reasoned that arsenate, which may substitute for phosphate in a number of biochemical (7, 8) and transport events, (2-6) would be a useful inhibitor for studying the various processes that involve phosphate and that affect solute transport. Accordingly, these studies describe the effects of arsenate on transport and metabolism by the proximal convoluted tubule, identify the dominant mechanism involved in the inhibitory effects, and 7 . Bathing media other than rabbit serum, when used, were made directly from the corresponding perfusion fluids by adding either, 3 g/dl dialyzed dextran, 40,000 mol wt (Pharmacia Fine Chemicals AB, Uppsala, Sweden), or 6 g/dl defatted albumin (11) , and enough calcium chlori(le for a final total calciumii concentration of3 mM. Before use, dextran was dialyzed exhaustively against doubly distilled wvater usinlg a Spectrapor membrane (Spectrumil Medical Industries Inic., Los Angeles, Calif.) with a nominal retention at 6-8,000 daltons. Dialysis removed lower molecular weight polymers aiid potential impurities. The concenitration of the dialyzed dextran was estimated by weighing an air-dried ali-(quot. This indicated that -10% of the original dextran was lost in the dialysis procedture. Ali(quots wvere frozen and stored until the day used.
Transport rates for phosphate and glucose were determined using radioisotopes. We meastured the lumeni-to-bath fluxes of phosphate (Jlh ) or glucose (J"),.), as the difference between the amount of solute delivered and the amount collected according to the balance e(quationi: (15) .
Studies using cortical tubule suspensions were performed in a specially designed, temperature controlled, sealed chamber (15) that permitted simultaneous measurements of' oxygen consumption and microfluorometry. To initiate an experiment, the tubule suspension was pre-equilibrated for min with 95% 02, 5% CO2 gas mixture at 37°C. An Fluorometric measurements were performed on the tubule suspension as described (15) . Briefly, the incident light on the chamber was obtained from a sharply filtered (366 nm peak) mercury arc lamp. Light was collected form the opposite side of the chamber by an objective lens focused near the center of the suspension. The collected light was focused on a beam splitter where 95% of the light was transmitted through a 450-nm filter to a photomultiplier tube. This photomultiplier tube recorded the fluorescent emission from NADH. The other 5% of the excitation and emitted light was directed through a 366-nm filter to a photomultiplier tube which recorded only the transmitted excitation light. This excitation light was subtracted electronically from the fluorescence signal to compensate for movement artifacts, for changes in the intensity of the arc lamp, and for scattering of light within the preparation (16) . All results are expressed as the difference between the 450-and the 366-nm signals. An increase in 450 nm fluorescence indicates a net reduction of mitochondrial NAD (i.e., an increase in the reduced to oxidized NAD ratio).2 2 Although NADH occurs in the cytoplasm as well as mitochondria, studies of skeletal muscle (17) , cardiac muscle (18) , and brain (19) indicate that >90% of the 450 nm fluorescence is attributable to bound mitochondrial rather than cytoplasmic NADH. Our own unpublished observations indicate that a similar situation exists for isolated proximal renal tubules.
A decrease in 450 nm fluoreseence indicates a net oxidation of NAD (i.e., a decrease in the reduced to oxidized NAD ratio). The data were quantified by comparing the changes in emission of 450 nim light that occurred with each experimental conidition to the intensity of emission that occurred during control conditions. This comparison is expressed as the percent change in fluorescence. All tubule suspensions were followved until anoxic conditions were achieved. The 0-100% range of the fluorescence signal was defined as the difference betwveen the control and the anoxic state. The data are reported as the mean percent change in fluorescence±SE for a givenl number of suspensions. Protein content of each suspension was determined by the method of Lowry et al. (20) .
As noted above, dextran replaced albumin or serum proteins in somne studies because albumin interfered with fluorometry. Preliminary studies established that dialyzed dextran (3 g/dl in the bath) was isoncotic to rabbit serum and had no effects on the transport of phosphate or glucose. That is, six proximal convoluited tubules were perfused with the standard artificial perfusate (see above), bathed initially with rabbit serumii, and subsequently with an isomotic fluid that contained 3 g/dl dialyzed dextran. Fluid absorption rates averaged 1.34 ±0.20 nl/mm min with rabbit serum and 1.34+0.16 nl/mm min with dextran solution. Lumen-to-bath phosphate transport averaged 6.35±1.88 and 6.32+2.00 pmol/mm-min, and glucose transport averaged 69.3+4.3 and 70.8±5.1 pmol/mm min during rabbit serum or dextran solution, respectively. These values wvere constant for at least 90 min after the change of fluid. Thus, dialyzed dextran at 3 g/dl in the bath supported volume, phosphate, and glucose transport to the same extent as serum proteins or albumilin (10) .
RESULTS
Transport studies. Fig. 1 is a dose-response curve for the effects of intraluminal arsenate on fluid and phosphate absorption in isolated proximal convoluted tubules. 15 tubules were perfused initially with an ultrafiltrate of the rabbit serum used as the bath. Under these conditions, fluid absorption rates averaged 1.08 ±0.10 nl/mm min and lumen-to-bath phosphate transport averaged 8.60± 1.63 pmol/mm -min. Perfusion rates averaged 12.06+0.81 nl/min and the phosphate concentration in the perfusate was 1.66±0.09 mM. The addition of arsenate to the perfusate to final concentrations of 10 ,iM-5 mM resulted in proportional reductions in both phosphate and fluid absorption rates. Arsenate in the perfusate had no effect on phosphate transport from bath to lumen which averaged 0.69+0.07 pmol/ mm min for four tubules. If added to the bath only, arsenate to concentrations of 5 mM had no effect on either fluid or phosphate absorption.
We also examined the effects of arsenate on glucose and PAH transport. For these studies, the phosphate concentration in the perfusion fluid averaged 1.67+0.08 mM. As shown in Table I , 1 mM arsenate in the perfusate had no effect on PAH secretion which averaged 319.9+67.0 fmol/mm -min for four proximal convoluted tubules. On the other hand, 1 mM arsenate in the perfusate reduced the lumen-to-bath flux of glucose from 66.1±6.0 to 56.8+4.6 pmol/mm min (P < 0.05; Table  II) . For these studies, the glucose concentration in the Inhibition of Renal Transport and Metabolism by Arsenate Similarly, Fig. 3 shows the relationship between the fractional reduction in glucose transport from lumen to bath and the fractional reduction in fluid absorption rates. Arsenate concentrations in the perfusate varied from 0.1 mM to 10 mM. The degree of inhibition of glucose transport is less than that of phosphate ( Fig. 2) but is similar to that observed for these degrees of reduction in fluid absorption that occur with reductions in intraluminal sodium concentration (10) . Accordingly, the data in Figs. 2 and 3 show that arsenate inhibits Metabolic sttudies. The inhibition of sodiuim, phosphate, and glucose transport by arsenate raised the possibility that arsenate may be acting as an inhibitor of cellular metabolism rather than as a specific inhibitor of transport. To determine any direct metabolic effects, we examined the effects of arsenate on oxygen consumption rates and on the redox state of NAD in suspensions of cortical tubules. Fig. 4 shows the effects of arsenate on the oxygen consumption rate and on the change in 450 nm fluorescence for a typical study. For this particular study, arsenate was added to the bathing medium for a final concentration of 10 mM. Because these tubules have open lumens, arsenate presumably has direct access to the luminal surface. As noted in Fig. 4 cence (15%). The simultaneous increase in oxygen consumption and decrease in NADH fluorescence are consistent with the uncoupling of oxygen consumption from the phosphorylation of ADP to ATP (8, 21, 22) and with the stimulation of cellular ATPase activity (22) . To distinguish these two possibilities, we repeated the studies in the presence of 0.5 mM ouabain to inhibit sodium-potassium ATPase activity totally, and thereby decrease the respiratory rate of the tissue. These conditions would tend to magnify any uncoupling action related to arsenate. Fig. 5 shows a representative study from this series. The addition of ouabain decreased the rate of oxygen consumption and increased NADH fluorescence (22) . The subsequent addition of arsenate increased oxygen consumption and decreased NADH fluorescence more dramatically than in Fig. 4 . From these data we favor the interpretation that arsenate acts by uncoupling oxidative phosphorylation, rather than by stimulating ATPase activity, although the participation of an ATPase not sensitive to ouabain cannot be excluded. Table IV lists the effects of different concentrations of arsenate on oxygen consumption rates and on changes in NADH fluorescence, as measured in four different preparations of tubules in the absence or presence of 0.5 mM ouabain. The preparations were exposed to each concentration of arsenate. Arsenate at concentrations >0.1 mM increased oxygen consumption and decreased NADH fluorescence progressively. As shown in Fig. 1 , Tables II and III, these are the same concentrations of arsenate that inhibit proximal sodium, phosphate, and glucose transport.
The preceding data indicate that the dominant effect of arsenate was to uncouple oxidative metabolism. To test this further, we examined the effect of m-chlorocarbonyl cyanide phenylhydrazone (CCCP), a known uncoupler of oxidative metabolism (23) . Because of apparent binding of CCCP to serum proteins, these studies were performed using dextran solution as the bathing medium. As shown in Table V , CCCP was added to the bath for a final concentration of 1 ,uM decreased fluid and phosphate absorption to the same degree (64.0 ±9.2 and 72.1±8.1%, respectively) but decreased glucose transport significantly less (42.5+6.4%, P < 0.02).
In separate studies, 1 ,uM CCCP increased oxygen consumption rates by 51.2±2.3% in four suspensions of cortical tubules. CCCP at 10 ,uM increased oxygen consumption by 115.3±11.0%. Fluorometric measurements were not possible because CCCP fluoresces. Nonetheless, the striking increase in oxygen consumption with the decrease in Jv indicate that CCCP acts under these conditions as a mitochondrial uncoupler similar to its action in other systeins (23) . Moreover, the pattern of inhibition of volume, phosphate, and glucose transport caused by CCCP is similar to that observed with arsenate.
DISCUSSION
The effects of arsenate on sodium, phosphate, and glucose absorption, NADH fluorescence, and oxygen consumption indicate that arsenate may act in the proximal tubule as an uncoupler of ATP production from mitochondrial respiration. The simultaneous increase in respiration and decrease in the level of mitochondrial NADLI associated with arsenate may be interpreted on the basis of known mitochondrial behavior.
Two types of conditions would elicit these responses in isolated mitochondria; either a transition to a more active state that would stimulate respiration and increase the rate of ATP production, or an uncoupling action that would stimulate respiration bust would inhibit ATP production (21, 22, 24) . The first response might have occurred if arsenate increased the rate of ATP use but this seems unlikely because arsenate decreased net sodium transport, a major pathway for the use of ATP (25, 26) . Moreover, the studies with ouabain (Table III) its metabolic effects even during complete inhibition of the sodium-potassium ATPase. Therefore, arsenateinduced increases in ATPase activity seem unlikely. Although we cannot exclude the possibility of activation of an ouabain-insensitive ATPase, the present data are most consistent with the interpretation that arsenate uncouples mitochondrial oxidative phosphorylation in intact proximal convoluted renal tubules as it does in the rat liver (8) .
In addition to its action as an uncoupler of oxidative phosphorylation, arsenate competes with phosphate for binding sites on glycolytic enzymes (7) and may be converted to arsenite (27) , a potent sulfhydryl group inhibitor that affects enzymes such as alpha-ketoglutarate and pyruvate dehydrogenases (28, 29) . If the metabolic effects of arsenate resulted from either of these two mechanisms, oxygen consumption would be expected to decrease because of fewer substrates available for the tricarboxylic acid cycle. Indeed, Crane and Lipmann (8) observed that arsenite decreased oxygen consumption by isolated mitochondria. In the present studies, the observed increase in oxygen consumption is not compatible with these mechanisms and suggests that these types of inhibition, if they do occur, are quantitatively unimportant. That is, arsenate's dominant mechanism appears to be inhibition of mitochondrial oxidative phosphorylation. In this regard, it should be noted that in the absence of ouabain, arsenate even at concentrations of 10 mM increased oxygen consumption by only 27%. This may be considered as Although there were some necessary differences in the conditions that prevailed during the transport and the metabolic studies, none seems so major as to preclude a general comparison of the concentration dependencies of the transport and metabolic effects of arsenate. Thus, we note from Fig. 1 and from Table IV that the effects of arsenate on fluid absorption and oxidative metabolism had their onset at similar concentrations of about 0.1 mM and that further changes occurred as the arsenate concentration was increased to 1 mM. These data suggest that a very tight relationship exists between net sodium transport and energy availability in the isolated proximal tubule. That is, although previous studies have demonstrated profound reductions in proximal fluid absorption in response to potent uncouplers of oxidative phosphorylation (30, 31) and to metabolic inhibitors such as cyanide (31, 32) , the present studies demonstrate graded reductions in transport in response to increasing concentrations of a weak uncoupler. To a first approximation, the graded reductions in fluid absorption (and phosphate absorption) correspond with the graded reductions in oxidative metabolism (Table IV) to complete, reductions provide opportunities to examine the relationship between oxidative metabolism and transport rates for specific solutes.
If one accepts the conclusion from these studies and others (8) that arsenate inhibits cellular metabolism and thus net sodium transport, it is perhaps not surprising that arsenate also reduces the absorption of phosphate and glucose. There is now abundant evidence that the transport of these two solutes is linked closely to sodium transport. The elimination of net sodium transport by ouabain eliminates the net transport of phosphate (33) and glucose (12) . The partial replacement of intraluminal sodium with choline causes proportional reductions in phosphate, glucose, and net sodium fluxes (10, 34, 35) . Moreover, specific symports for sodium and phosphate (6), and for sodium and glucose (36-38) have been described for the brush border of the proximal renal tubule. Thus, there seems to be little question that cotransport of sodium and phosphate, and sodium and glucose occur at some point, probably the brush border, in the series of events that results ultimately in the absorption of these solutes.
The present data emphasize, however, that despite their common dependency on sodium transport, glucose transport and phosphate transport are inhibited to different degrees by various conditions that partially inhibit net sodium transport. Whether caused by arsenate or CCCP as in the present studies ( Figs. 1-3 Inhibition of Renal Transport and letabolism by Arsenatetion occurred via replacement of intraluminal sodium with choline (10) . Second, although these methods of inhibition may reduce the electrochemical gradient for sodium that apparently mediates the cellular accumulation of phosphate and glucose, these two solutes may be coupled differently to this gradient. The result is that phosphate transport may be more sensitive to a partial reduction than glucose transport. For example, a greater portion of phosphate entry may depend on the chemical gradient for sodium, whereas a greater portion of glucose entry may depend on the transmembrane electrical potential. In this regard, Beck and Sacktor (37, 38) demonstrated that electrical potentials are sufficient to cause glucose uptake across membrane vesicles from the rabbit proximal tubule even in the absence of a chemical gradient for sodium. On the other hand, Hoffman et al. (6) , and Barrett et al. (40) demonstrated that phosphate uptake into membrane vesicles is affected only slightly by electrial potential, and that much of the phosphate entry may occur via neutral complexes. Our own studies (10) show that the presumed depolarization of the proximal luminal membrane by the initiation of glucose transport also inhibits phosphate transport only slightly. Accordingly, if partial inhibition of cellular metabolism via arsenate or CCCP, or replacement of intraluminal sodium with choline reduces the chemical gradient for sodium more than the electrical potential, phosphate entry might be reduced more readily than glucose entry. Alternatively, a component of glucose entry may occur independently of sodium transport, although this seems unlikely in view of the observations that ouabain (12) or removal of sodium (35) eliminates glucose absorption.
There may be other explanations for the differential inhibition of phosphate and glucose transport that occurs with the partial inhibition of net sodium transport. Indeed, the various possibilities are not mutually exclusive and may combine. Further clarifications will require measurements of changes in intracellular electrical potentials and ionic concentrations.
The partial inhibition of metabolism achieved in these studies with arsenate did not cause any alteration in the rate of PAH secretion. In view of the present uncertainty regarding the existence of PAH coupling to sodium transport (41, 42) , these results indicate only that PAH secretion is not critically dependent on a completely intact oxidative phosphorylation system. Finally, we should comment further on the experiments in which phosphate was removed from the perfusate. These results demonstrated that elimination of phosphate transport by itself had no discernible effect on fluid absorption. This was expected because phosphate efflux from the lumen at 8 pmol/mm min can account for, potentially, only about 5% of net sodium transport that averages about 150 pmol/mm min (43) .
In summary, partial as opposed to complete inhibition of net sodium transport by the proximal convoluted tubule reveals that phosphate transport is reduced much more profoundly than glucose or PAH transport. Thus, although the transport of these solutes may be sodium dependent, variability exists in the linkage of specific solute transport processes to net sodivum transport.
